Regressive change in high-grade ductal carcinoma in situ of the breast: Histopathologic spectrum and biologic importance

American Journal of Clinical Pathology

Volumn 144, Issue 3, 2015, Pages 503-510

  Wasserman, Jason K ^a   Parra Herran, Carlos ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Breast cancer; Breast pathology; Ductal carcinoma in situ; Regression

Indexed keywords

ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST BIOPSY; CANCER REGRESSION; CANCER SURGERY; CD4 CD8 RATIO; FEMALE; HIGH GRADE DUCTAL CARCINOMA IN SITU; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR INVASION; TUMOR VOLUME; BREAST; BREAST NEOPLASMS; CANCER GRADING; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY;

ADULT; AGED; BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM GRADING;

EID: 84946733828     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPW4EADZ9BNXXM     Document Type: Article

References (29)

1. Everson TC, Cole WH. Spontaneous Regression of Cancer. Philadelphia, PA: Saunders; 1966.
2. Muir R, Aitkenhead A. The healing of intra-duct carcinoma of mamma. J Pathol. 1934;18:115-127.
3. Chivukula M, Domfeh A, Carter G, et al. Characterization of high-grade ductal carcinoma in situ with and without regressive changes: diagnostic and biologic implications. Appl Immunohistochem Mol Morphol. 2009;17:495-499.
4. Cole WH. Spontaneous regression of cancer: the metabolic triumph of the host? Ann N Y Acad Sci. 1974;230:111-141.
5. Diede SJ. Spontaneous regression of metastatic cancer: learning from neuroblastoma. Nat Rev Cancer. 2014;14:71-72.
6. Kalialis LV, Drzewiecki KT, Klyver H. Spontaneous regression of metastases from melanoma: review of the literature. Melanoma Res. 2009;19:275-282.
7. Challis GB, Stam HJ. The spontaneous regression of cancer: a review of cases from 1900 to 1987. Acta Oncol. 1990;29:545-550.
8. Papac RJ. Spontaneous regression of cancer: possible mechanisms. In Vivo. 1998;12:571-578.
9. Horii R, Akiyama F, Kasumi F, et al. Spontaneous "healing" of breast cancer. Breast Cancer. 2005;12:140-144.
10. Larsen SU, Rose C. Spontaneous remission of breast cancer: a literature review [in Danish]. Ugeskr Laeger. 1999;161:4001-4004.
11. Tokunaga E, Okano S, Nakashima Y, et al. Spontaneous regression of breast cancer with axillary lymph node metastasis: a case report and review of literature. Int J Clin Exp Pathol. 2014;7:4371-4380.
12. Dussan C, Zubor P, Fernandez M, et al. Spontaneous regression of a breast carcinoma: a case report. Gynecol Obstet Invest. 2008;65:206-211.
13. Zahl P-H, Maehlen J, Welch HG. The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med. 2008;168:2311-2316.
14. Zahl P-H, Andersen JM, Maehlen J. Spontaneous regression of cancerous tumors detected by mammography screening. JAMA. 2004;292:2579-2580.
15. Sheu B-C, Kuo W-H, Chen R-J, et al. Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer. Breast. 2008;17:604-610.
16. Bilik R, Mor C, Hazaz B, et al. Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer. Cancer Immunol Immunother. 1989;28:143-147.
17. Müller MR, Grünebach F, Nencioni A, et al. Transfection of dendritic cells with RNA induces CD4-and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes. J Immunol. 2003;170:5892-5896.
18. Bobrow LG, Happerfield LC, Gregory WM, et al. The classification of ductal carcinoma in situ and its association with biological markers. Semin Diagn Pathol. 1994;11:199-207.
19. Tang P, Wang X, Schiffhauer L, et al. Relationship between nuclear grade of ductal carcinoma in situ and cell origin markers. Ann Clin Lab Sci. 2006;36:16-22.
20. Dabbs DJ, Chivukula M, Carter G, et al. Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile. Mod Pathol. 2006;19:1506-1511.
21. Tang P, Wang X, Schiffhauer L, et al. Expression patterns of ER-alpha, PR, HER-2/neu, and EGFR in different cell origin subtypes of high grade and non-high grade ductal carcinoma in situ. Ann Clin Lab Sci. 2006;36:137-143.
22. Gruvberger S, Ringnér M, Chen Y, et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 2001;61:5979-5984.
23. Pinder SE, Duggan C, Ellis IO, et al. A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial. Br J Cancer. 2010;103:94-100.
24. Kim J, Han W, Lee JW, et al. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Breast. 2012;21:641-645.
25. Wallis MG, Clements K, Kearins O, et al. The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS. Br J Cancer. 2012;106:1611-1617.
26. Collins LC, Tamimi RM, Baer HJ, et al. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study. Cancer. 2005;103:1778-1784.
27. Yen TWF, Hunt KK, Ross MI, et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg. 2005;200:516-526.
28. Hoorntje LE, Schipper MEI, Peeters PHM, et al. The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy. Ann Surg Oncol. 2003;10:748-753.
29. Huo L, Sneige N, Hunt KK, et al. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer. 2006;107:1760-1768.